At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on.

DexCom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily tracks real-time glucose ...

Oppenheimer downgraded DexCom (DXCM) to Perform from Outperform without a price target after assuming coverage of the name. The company is doing ...

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s ...

(Reuters) -Dexcom said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. Stelo was cleared by the U.S. health ...

Over the next few quarters, Dexcom could profit from the possibility to link Dexcom sensors with the Apple Watch.

Dexcom, the San Diego-based maker of continuous glucose monitors for diabetes patients and prediabetics, announced Wednesday ...

The DexCom sensor is life-altering for patients because of convenience, elimination of pain, and, most importantly, real-time glucose levels that can provide insights and analytics.

Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps ...

Dexcom ONE+ is now available in the UK, incorporating 25 years of Dexcom research to offer a sensor that better meets the needs of those living with diabetes. Dexcom’s first-ever State of Type 2 ...